Savara Inc Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Savara Inc (SVRA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $9.39 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- Savara Inc net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was $9.39M.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$39.05M.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$33.44M.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $3.44M.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$69.11M.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$8.00K, a 100.24% decline from fiscal 2015.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $3.40M, a 605.82% increase from fiscal 2014.
- Savara Inc net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $481.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $9.39M 10-Q · filed 2018-05-09 | -$29.66M derived: sum of 2 quarters · filed 2018-05-09 | -$63.11M derived: sum of 3 quarters · filed 2018-05-09 | -$59.67M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | -$39.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$72.50M derived: sum of 2 quarters · filed 2018-03-14 | -$69.06M derived: sum of 3 quarters · filed 2018-03-14 | -$69.11M 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | -$33.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$30.00M derived: sum of 2 quarters · filed 2017-11-08 | -$30.06M 10-Q · filed 2017-11-08 | -$30.06M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.38M 10-Q · filed 2017-08-09 | $3.38M derived: sum of 3 quarters · filed 2018-05-09 | $3.38M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | -$59.00K 10-Q · filed 2018-05-09 | $2.83M 10-Q · filed 2017-05-09 | -$59.00K derived: sum of 2 quarters · filed 2018-05-09 | -$62.00K derived: sum of 3 quarters · filed 2018-05-09 | -$4.45M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$3.00K derived: sum of 2 quarters · filed 2018-03-14 | -$4.39M derived: sum of 3 quarters · filed 2018-03-14 | -$8.00K 10-K · filed 2018-03-14 | $15.20M 10-K · filed 2017-03-06 | |||
| 2016-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$4.39M derived: sum of 2 quarters · filed 2017-11-08 | -$8.00K 10-Q · filed 2017-11-08 | $11.51M 10-Q · filed 2016-11-08 | -$304.00K derived: sum of 4 quarters · filed 2017-11-08 | |||
| 2016-06-30 | -$4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$5.00K 10-Q · filed 2017-08-09 | $7.36M 10-Q · filed 2016-08-09 | -$301.00K derived: sum of 3 quarters · filed 2017-08-09 | $4.13M derived: sum of 4 quarters · filed 2017-08-09 | |||
| 2016-03-31 | $4.38M 10-Q · filed 2017-05-09 | $4.08M derived: sum of 2 quarters · filed 2017-05-09 | $8.51M derived: sum of 3 quarters · filed 2017-05-09 | $8.29M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | -$296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $4.13M derived: sum of 2 quarters · filed 2017-03-06 | $3.91M derived: sum of 3 quarters · filed 2017-03-06 | $3.40M 10-K · filed 2017-03-06 | ||||
| 2015-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $4.21M derived: sum of 2 quarters · filed 2016-11-08 | $3.69M 10-Q · filed 2016-11-08 | -$710.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | -$221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$740.00K 10-Q · filed 2016-08-09 | -$5.14M derived: sum of 3 quarters · filed 2017-03-06 | -$2.33M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | -$519.00K 10-Q · filed 2016-05-06 | -$4.92M derived: sum of 2 quarters · filed 2017-03-06 | -$2.11M derived: sum of 3 quarters · filed 2017-03-06 | -$2.50M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$1.59M derived: sum of 2 quarters · filed 2017-03-06 | -$1.98M derived: sum of 3 quarters · filed 2017-03-06 | $481.00K 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.42M derived: sum of 2 quarters · filed 2015-11-12 | $4.88M 10-Q · filed 2015-11-12 | $4.88M 10-Q · filed 2014-10-31 | $5.31M derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-06-30 | -$392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $2.07M 10-Q · filed 2015-08-12 | $2.07M 10-Q · filed 2014-08-11 | $2.50M derived: sum of 3 quarters · filed 2015-08-12 | -$8.23M derived: sum of 4 quarters · filed 2015-08-12 | |||
| 2014-03-31 | $2.46M 10-Q · filed 2015-05-11 | $2.89M derived: sum of 2 quarters · filed 2015-05-11 | -$7.84M derived: sum of 3 quarters · filed 2015-05-11 | |||||
| 2013-12-31 | $426.38K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | -$10.30M derived: sum of 2 quarters · filed 2015-03-24 | -$4.77M 10-K · filed 2015-03-24 | |||||
| 2013-09-30 | -$10.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$5.19M 10-Q · filed 2014-10-31 | ||||||
| 2013-06-30 | $5.54M 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |